Internal Medicine, Saint Luke's Hospital, Milwaukee, Wisconsin (2009)
Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin (2013)
Radiation Oncology, American Board of Radiology (2014)
MD, Medical College of Wisconsin, Milwaukee, WI, 2008
PhD, Cell Biology, Medical College of Wisconsin, Milwaukee, WI 2006
MPhil, Epidemiology, Cambridge University, Cambridge, UK, 1999
SB, Chemical Engineering and Biology, MIT, Cambridge, MA, 1988
The Bergom laboratory embraces collaborative research and also prioritizes the education and training of students and post-doctoral fellows.
This diagram outlines the two main arms of the laboratory (Figure 1).
We have a research program focusing on using unique genetic models and next generation sequencing to enhance the therapeutic ratio of radiation and chemotherapy. Our research program uses these models to identify targets that will allow better tailored radiation therapy and chemotherapy, by enhancing tumor responses to therapy and minimizing radiation- and chemotherapy-induced side effects, specifically treatment-induced cardiotoxicity. Our tumor studies are specifically focusing on the role of the tumor microenvironment in breast cancer treatment responses. The goals of these studies are to identify predictive and prognostic features of breast cancer to better classify and treat breast and other cancers, and ultimately to identify new treatment strategies to improve patient outcomes.
(Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A.) Biomed Opt Express. 2018 Jun 01;9(6):2543.
(Currey A, Patten CR, Bergom C, Wilson JF, Kong AL.) Breast J. 2018 Nov;24(6):902-910.
(Flister MJ, Bergom C.) Trends Cancer. 2018 06;4(6):429-444.
(Bergom C, Currey A, Desai N, Tai A, Strauss JB.) Front Oncol. 2018;8:87.
(Jagtap J, Sharma G, Parchur AK, Gogineni V, Bergom C, White S, Flister MJ, Joshi A.) Biomed Opt Express. 2018 Feb 01;9(2):543-556.
(Maranto C, Udhane V, Hoang DT, Gu L, Alexeev V, Malas K, Cardenas K, Brody JR, Rodeck U, Bergom C, Iczkowski KA, Jacobsohn K, See W, Schmitt SM, Nevalainen MT.) Clin Cancer Res. 2018 Apr 15;24(8):1917-1931.
(Kimmick GG, Li X, Fleming ST, Sabatino SA, Wilson JF, Lipscomb J, Cress R, Bergom C, Anderson RT, Wu XC, Written on behalf of the Center for Disease Control and Prevention National Program of Cancer Registry Patterns of Care Study Group.) J Geriatr Oncol. 2018 May;9(3):214-220.
Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
(Hall WA, Bergom C, Thompson RF, Baschnagel AM, Vijayakumar S, Willers H, Li XA, Schultz CJ, Wilson GD, West CML, Capala J, Coleman CN, Torres-Roca JF, Weidhaas J, Feng FY.) Int J Radiat Oncol Biol Phys. 2018 Jun 01;101(2):274-284.
(Gonyo P, Bergom C, Brandt AC, Tsaih SW, Sun Y, Bigley TM, Lorimer EL, Terhune SS, Rui H, Flister MJ, Long RM, Williams CL.) Oncogene. 2017 12 14;36(50):6873-6883.
(Flister MJ, Tsaih SW, Stoddard A, Plasterer C, Jagtap J, Parchur AK, Sharma G, Prisco AR, Lemke A, Murphy D, Al-Gizawiy M, Straza M, Ran S, Geurts AM, Dwinell MR, Greene AS, Bergom C, LaViolette PS, Joshi A.) Breast Cancer Res Treat. 2017 Aug;165(1):53-64.
(Fish BL, Gao F, Narayanan J, Bergom C, Jacobs ER, Cohen EP, Moulder JE, Orschell CM, Medhora M.) Health Phys. 2016 11;111(5):410-9.
(Bergom C, Kelly T, Bedi M, Saeed H, Prior P, Rein LE, Szabo A, Wilson JF, Currey AD, White J.) Int J Radiat Oncol Biol Phys. 2016 09 01;96(1):65-71.